US EditionPublished • loading... • Updated
Glp-1: Scientific Promises and Media Enthusiasm - 10/01/2026 - Balance and Health
Summary by Folha De S.Paulo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
In Brazil and the rest of the world, the agonist drugs of GLP-1, such as semagutida (Ozempic, Wegovy), liraglutida (Saxenda) and tirzepatida (Mounjaro, Zepbound), became protagonists of a true valanche of not everyone who deserves attention. Read more (01/10/2026
·São Paulo, Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
